Johns Hopkins ABX GuideAntibioticsBiological

Bezlotoxumab

Kathryn Dzintars, Pharm.D., BCPS
Bezlotoxumab is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

Reduce the recurrence of Clostridium difficile infections (CDIs) in patients 18 years of age and older who are receiving antibacterial CDI drug treatment and are at high risk for CDI recurrence.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: March 4, 2018

Citation

TY - ELEC T1 - Bezlotoxumab ID - 540676 A1 - Dzintars,Kathryn,Pharm.D., BCPS Y1 - 2018/03/04/ PB - Johns Hopkins ABX Guide UR - https://www.unboundmedicine.com/medline/view/Johns_Hopkins_ABX_Guide/540676/all/Bezlotoxumab ER -